Skip to main content
Equibles

ROYAL BANK OF CANADA

Bank

Position in VERU — Veru Inc.

CIK 1000275 TORONTO, A6
Back to VERU Full portfolio

Position in VERU

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$15,121
-$11,927 QoQ
Shares Held
4,831
-60.5% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#36
of 61 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VERU Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $2,118,794,122 across 427 Biotechnology names. VERU ranks #250 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IONS
Ionis Pharmaceuticals Inc
 6,182,479 $490,208,754
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 980,259 $486,924,048
3 ALNY
Alnylam Pharmaceuticals, Inc.
 875,859 $263,659,830
4 INCY
Incyte Corp
 1,132,050 $128,329,182
5 REGN
Regeneron Pharmaceuticals, Inc.
 174,515 $108,817,078
6 MRNA
Moderna, Inc.
 944,457 $66,140,319
7 INSM
INSMED Inc
 416,487 $44,405,840
8 HALO
Halozyme Therapeutics, Inc.
 545,761 $42,716,712

All Filings in VERU

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $15,121 4,831
2026-03-31 $27,048 12,239
2025-12-31 $15,474 7,231
2025-09-30 $3,040 800
2025-06-30 $3,108 5,360
2025-03-31 $3,988 8,140
2024-12-31 $6,797 10,458
2024-09-30 $15,139 19,664
2024-06-30 $15,476 18,424
2024-03-31 $3,500 5,000
2023-12-31 $4,212 5,850
2023-09-30 $3,754 5,215
2023-06-30 $4,581 3,850
2023-03-31 $13,089 11,285
2022-12-31 $1,357,376 257,079
2022-09-30 $5,161,488 448,046
2022-06-30 $2,802,601 248,018
2022-03-31 $1,223,669 253,348
2021-12-31 $152,208 25,842
2021-09-30 $168,594 19,765
2021-06-30 $107,265 13,292
2021-03-31 $106,667 9,895
2020-12-31 $13,718 1,586
2020-09-30 $335 128
2020-06-30 $21,412 6,411
2020-03-31 $20,963 6,411